Ocaliva (Intercept Pharmaceuticals Inc)
Welcome to the PulseAid listing for the Ocaliva drug offered from Intercept Pharmaceuticals Inc. This Farnesoid X Receptor Agonist [EPC],Farnesoid X Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Intercept Pharmaceuticals Inc |
| NON-PROPRIETARY NAME: | Obeticholic Acid |
| SUBSTANCE NAME: | OBETICHOLIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Farnesoid X Receptor Agonist [EPC],Farnesoid X Receptor Agonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-05-27 |
| END MARKETING DATE: | 0000-00-00 |
Ocaliva HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ocaliva from Intercept Pharmaceuticals Inc |
| LABELER NAME: | Intercept Pharmaceuticals Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2016-05-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69516-005_d7cea5d6-ee56-4bbc-a831-e4170ce99f75 |
| PRODUCT NDC: | 69516-005 |
| APPLICATION NUMBER: | NDA207999 |
Other OBETICHOLIC ACID Pharmaceutical Manufacturers / Labelers:
